Abciximab reduced death, MI, and urgent target vessel revascularization in non-ST-segment elevation acute coronary syndromes

July 2006
ACP Journal Club;Jul/Aug2006, Vol. 145 Issue 1, p8
Academic Journal
The article presents a study which states that myocardial infraction (MI) and urgent target vessel revascularization in non-ST-segment elevation acute coronary syndromes (ACS) can be reduced by using Abciximab. The study was conducted at seven clinical centers in the Netherlands, Germany and Brazil on 2022 patients, who had non-ST-segment elevation ACS. The abciximab group had a lower tendency of the composite endpoint and MI than the placebo group. The group do not differ for major and minor bleeding.


Related Articles

  • The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease Dyszkiewicz, Wojciech; Jemielity, Marek; Piwkowski, Cezary; Kasprzyk, Mariusz; Perek, Bartłomiej; Gasiorowski, Lukasz; Kaczmarek, Elżbieta // European Journal of Cardio-Thoracic Surgery;Sep2008, Vol. 34 Issue 3, p531 

    Abstract: Objective: The aim of this study was to analyze the early and long-term results of simultaneous surgical treatment of both coronary heart disease (CHD) and lung cancer. Methods: Twenty-five patients with the diagnoses of both non-small cell lung cancer (NSCLC) and unstable angina were...

  • Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis. Klauss, V.; Erdin, P.; Rieber, J.; Leibig, M.; Stempfle, H-U.; König, A.; Boylacher, M.; Thesen, K.; Haufe, M. C.; Sroczynski, G.; Schiele, T.; Siebert, U. // Heart;Feb2005, Vol. 91 Issue 2, p203 

    Objective: To determine the prognostic value of fractional flow reserve (FFR) measurements after coronary stent implantation including multiple clinical and angiographic parameters collected in one centre. Methods: 119 consecutive patients were enrolled who had a stent implanted with the use of...

  • Early revascularisation of no benefit in mild heart attacks. Josefson, Deborah // BMJ: British Medical Journal (International Edition);06/27/98, Vol. 316 Issue 7149, p1928 

    Provides information on a study involving a number of patients who were assigned to conservative management for heart attacks, which is superior to early revascularisation. What conservative management consisted of; Details on the treatment of the patients; Percentage of patients who underwent...

  • Myocardial Revascularization for Acute and Chronic Coronary Heart Disease. Swan, H. J. C.; Chatterjee, Kanu; Corday, Eliot; Ganz, William; Marcus, Harold; Matloff, Jack; Parmley, William // Annals of Internal Medicine;Dec73, Vol. 79 Issue 6, p851 

    Discusses the use of myocardial revascularization for acute and chronic coronary heart disease. Indications for myocardial revascularization; Indications for bypass surgery; Hemodynamic and angiographic evaluation of candidates for myocardial revascularization; Selection of patients for...

  • The rise and fall of cardiac rehabilitation in the United Kingdom since 1998. Hugh J. N. Bethell; Julia A. Evans; Sally C. Turner; Robert J. P. Lewin // Journal of Public Health;Vol. 29 Issue 1, p57 

    Background Provision of cardiac rehabilitation is inadequate in all countries in which it has been measured. This study assesses the provision in the United Kingdom and the changes between 1998 and 2004.Methods All UK cardiac rehabilitation programmes were surveyed annually. Figures for each...

  • Evaluation of the unstable angina patient in 2005: is there still a role for noninvasive risk stratification? Brown, Kenneth A. // Journal of Nuclear Cardiology;Jan2005, Vol. 12 Issue 1, p9 

    The author discusses the possible role for noninvasive risk stratification on the evaluation of patient with unstable angina in 2005. He states that patients with unstable angina have an increased risk of death or myocardial infarction (MI) compared with patients with stable angina. He mentions...

  • Secondary Prevention After Acute Myocardial Infarction and Coronary Revascularisation: Focus on Angiotensin Converting Enzyme Inhibitors. Juan Kaski; Daniel Fernandez-Berges // Cardiovascular Drugs & Therapy;Jun2008, Vol. 22 Issue 3, p185 

    Abstract Introduction  Cardiovascular disease (CVD) is responsible for an estimated one third of all deaths worldwide. Patients and methods  One group of patients who are at a particularly high risk of cardiovascular events and death are those with stable coronary artery disease...

  • Diabetes and cholesterol.  // GP: General Practitioner;8/18/2006, p30 

    The article presents information on new research findings related to diabetes and cholesterol. Statins have been considered effective in many research studies for the primary and secondary prevention of cardiovascular disease in patients with diabetes. The Heart Protection Study showed that the...

  • Long-Term Follow-up of Primary Stenting with Coil Stent in Acute Myocardial Infarction. Yano, Michiko; Yoshitomi, Yuji; Kojima, Shunichi; Sugi, Toshihiko; Matsumoto, Yuji; Kuramochi, Morio // Angiology;Feb2000, Vol. 51 Issue 2, p107 

    The authors evaluated clinical and angiographic outcomes for 1 year after primary stenting using coil stent for acute myocardial infarction. Twenty-eight patients underwent primary stenting with coil stent. Follow-up coronary arteriography at 3 months and 1 year was planned in all patients....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics